Research / STE / Fundamental state Inspectable configuration
State dimensions Filing 0001757898-23-000013 General Corporate
Debt relative to revenue 83th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.debt_to_revenue
250.77% · OPTIONAL · VALID
Capex intensity 17th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.capex_revenue_ratio
6.20% · OPTIONAL · VALID
Operating cash generation 11th Own-history percentile · N=18
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
10.88% · OPTIONAL · VALID
Revenue growth 64th Own-history percentile · N=14
Evidence method Yoy · gp.fundamentals.revenue
11.82% · CORE · VALID
Inventory pressure 94th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
61.17% · OPTIONAL · VALID
Gross margin 78th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.gross_margin
44.22% · CORE · VALID
Operating margin 33th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.operating_margin
13.85% · CORE · VALID
R&D intensity 22th Own-history percentile · N=18
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
2.01% · OPTIONAL · VALID
SBC intensity 94th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
1.54% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 30 states Self-history eligible
Sep 30, 2021 8/9 normalized Level 3 Dec 31, 2021 8/9 normalized Level 3 Mar 31, 2022 9/9 normalized Level 3 Jun 30, 2022 9/9 normalized Level 3 Sep 30, 2022 9/9 normalized Level 3 Dec 31, 2022 9/9 normalized Level 3 Mar 31, 2023 9/9 normalized Level 3 Jun 30, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Dec 31, 2023 9/9 normalized Level 3 Mar 31, 2024 9/9 normalized Level 3 Jun 30, 2024 9/9 normalized Level 3 Sep 30, 2024 9/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 222.66%
Current 250.77%
Delta 28.11% Capex Intensity Increased
Previous 5.18%
Current 6.20%
Delta 1.02% Cash Generation Decreased
Previous 21.89%
Current 10.88%
Delta -11.00% Growth Increased
Previous 11.07%
Current 11.82%
Delta 0.74% Inventory Pressure Increased
Previous 59.85%
Current 61.17%
Delta 1.32% Margin Decreased
Previous 44.64%
Current 44.22%
Delta -0.43% Profitability Decreased
Previous 14.70%
Current 13.85%
Delta -0.86% R And D Intensity Increased
Previous 1.99%
Current 2.01%
Delta 0.03% Sbc Intensity Increased
Previous 0.90%
Current 1.54%
Delta 0.64% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.